-
For the past year, Bayer has tried to marry its drug business to Akzo Nobel and others--but only if Bayer could keep control.
FORBES: Bayer backs down
-
Pfizer is also developing a second antipsychotic, asenapine, with Akzo Nobel (nasdaq: AKZOY - news - people ).
FORBES: Pfizer Antipsychotic Gets New Approval
-
Moreover, the company has had a string of regulatory disappointments with medicines like indiplon, a sleeping pill, and more recently an antipsychotic that it was developing with Akzo Nobel (nasdaq: AKZOY - news - people ).
FORBES: Pfizer: Still In The Game
-
But at least three of the research sites being shut down stand out: those that were originally part of Organon, the pharmaceutical-making arm of the Dutch chemicals giant Akzo Nobel.
FORBES: Merck Shutters Productive Labs